Efficacy of first-line treatment options in advanced HER2-altered non-small cell lung cancer: A multi-center retrospective study

被引：0
|
作者：
Sun, H. [1 ,2 ]
Ge, Y. [1 ]
Wu, J. [1 ]
Sun, Y. [1 ]
Zhang, J. [1 ]
Cheng, Q. [1 ]
Wang, D. [1 ]
Wang, X. [1 ]
Li, J. [1 ]
Fu, X. [2 ]
Sun, H. [1 ,2 ]
Gao, A. [2 ]
机构：
[1] Shandong First Med Univ, Phase Clin Res Ctr 1, Canc Hosp, Jinan, Peoples R China
[2] Shandong First Med Univ, Dept Thorac Radiat Oncol, Canc Hosp, Jinan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2420
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1387P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of first-line dacomitinib in Japanese patients with advanced non-small cell lung cancer
    Nishio, Makoto
    Kato, Terufumi
    Niho, Seiji
    Yamamoto, Noboru
    Takahashi, Toshiaki
    Nogami, Naoyuki
    Kaneda, Hiroyasu
    Fujita, Yuka
    Wilner, Keith
    Yoshida, Mizuki
    Isozaki, Mitsuhiro
    Wada, Shinsuke
    Tsuji, Fumito
    Nakagawa, Kazuhiko
    CANCER SCIENCE, 2020, 111 (05) : 1724 - 1738
  • [32] Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer
    Merimsky, Ofer
    Cheng, Chi-Kin
    Au, Joseph Siu-Kie
    Von Pawel, Joachim
    Reck, Martin
    ONCOLOGY REPORTS, 2012, 28 (02) : 721 - 727
  • [33] Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer
    Fujii, Hironori
    Araki, Ayumu
    Iihara, Hirotoshi
    Kaito, Daizo
    Hirose, Chiemi
    Kinomura, Motohiko
    Yamazaki, Mizuki
    Endo, Junki
    Inui, Toshiya
    Yanase, Komei
    Sasaki, Yuka
    Gomyo, Takenobu
    Sakai, Chizuru
    Kawae, Daisuke
    Kitamura, Yu
    Fukui, Masachika
    Kobayashi, Ryo
    Ohno, Yasushi
    Suzuki, Akio
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (04)
  • [34] First-line treatment for advanced non-small-cell lung cancer
    Laskin, Janessa J.
    Sandler, Alan B.
    ONCOLOGY-NEW YORK, 2005, 19 (13): : 1671 - 1676
  • [35] HER2-Altered Non-Small Cell Lung Cancer: A Journey from Current Approaches to Emerging Strategies
    Ferrari, Giorgia
    Del Rio, Benedetta
    Novello, Silvia
    Passiglia, Francesco
    CANCERS, 2024, 16 (11)
  • [36] Immunotherapy as first-line treatment in metastatic non-small cell lung cancer: A single center experience
    Rauthan, A.
    Patil, P.
    Lahkar, K.
    Murthy, N. Y.
    Vundemodalu, P.
    Ashwath, R.
    Jomi, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S1576 - S1576
  • [37] First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly
    Losanno, Tania
    Gridelli, Cesare
    CURRENT ONCOLOGY REPORTS, 2021, 23 (10)
  • [38] The use of pemetrexed for the first-line treatment of non-small cell lung cancer
    Silva, S.
    Colquitt, J.
    Hatton, M. Q.
    Mohanamurali, J.
    Lee, C.
    Danson, S.
    Fisher, P.
    Woll, P.
    LUNG CANCER, 2014, 83 : S13 - S13
  • [39] First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly
    Tania Losanno
    Cesare Gridelli
    Current Oncology Reports, 2021, 23
  • [40] Oral tyrosine kinase inhibitors in the first-line treatment of advanced non-small cell lung cancer
    Gori, Bruno
    Ricciardi, Serena
    Del Signore, Ester
    Fulvi, Alberto
    de Marinis, Filippo
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 : S55 - S60
12345